AshwagandhavsTaurine

Ashwagandha's withanolide compounds (withaferin A, withanolide A, withanone) modulate the hypothalamic-pituitary-adrenal (HPA) axis, reducing corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) signaling, thereby lowering cortisol production by 25-30% in stressed individuals. It acts as a GABA-A receptor positive allosteric modulator at the benzodiazepine site, producing anxiolytic effects without sedation. Ashwagandha inhibits acetylcholinesterase (AChE), raising acetylcholine levels in the hippocampus and cortex. The withanolides have anti-inflammatory properties via inhibition of NF-κB and COX-2, and antioxidant effects that reduce neuroinflammation and oxidative stress. It may support neurogenesis through upregulation of BDNF and its receptor TrkB, and modulation of the PI3K/Akt pathway.

Taurine activates GABA-A receptors (particularly extrasynaptic δ-containing subtypes) and glycine receptors (GlyR) as a partial agonist, providing inhibitory modulation that reduces neural excitability and hyperexcitability. It acts as a powerful antioxidant, scavenging hypochlorous acid, hydroxyl radicals, and peroxynitrite in mitochondria and cytosol. Taurine regulates calcium homeostasis via modulation of ryanodine receptors and IP3 receptors, preventing excitotoxic calcium overload. It modulates osmotic balance through the taurine transporter (TauT/SLC6A6) to protect cells from swelling under stress. Taurine may enhance mitochondrial function and biogenesis. Recent research shows it maintains telomere length, reduces cellular senescence markers (p16, p21), and modulates the mTOR pathway.